Clin2
NCT07500181Possibly a fitRecruiting

Testing the safety of a new antibiotic in healthy adults

Healthy

This trial tests an investigational antibiotic called BAL2420 to see if it is safe and how the body processes it. Healthy volunteers are needed to help determine the right dose before it can be studied in people with infections.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
136 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be between 18 and 30 on the body mass index (BMI) scale.
  • You must weigh more than 110 pounds (50 kg).
  • You cannot have any serious or uncontrolled medical conditions.
  • You cannot have an active infection or have been sick in the past 5 days.
  • You cannot smoke, vape, or use nicotine products in the last 6 months.
  • You cannot take any prescription or over-the-counter medications (except birth control) within 14–30 days before the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07876076Not yet recruiting· Phase 1
Testing a new medicine for safety in healthy adults

This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.

NCT06577337Recruiting· Phase 1
Testing a new drug (M5542) in healthy volunteers

This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.

Neu-Ulm
NCT07606976Not yet recruiting· Phase 1
Study of a new medicine in healthy adults

This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.

Shanghai
NCT06745297Recruiting· Phase 1
Testing a new medicine in healthy men for safety

This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.

Berlin
NCT07797855Recruiting· Phase 1
Testing a new medicine's safety in healthy people

This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.

Groningen
NCT07029932Recruiting· Phase 1
Testing the safety of multiple doses of BWC0977 in healthy people

This study tests an experimental antibiotic called BWC0977 to see if it is safe and well-tolerated when given as single and multiple doses. It is for healthy volunteers to understand how the drug behaves in the body before moving to patient trials.

Melbourne, Victoria

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.